BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21108457)

  • 1. Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation.
    Nguyen PL; Chen MH; Goldhaber SZ; Martin NE; Beard CJ; Dosoretz DE; Katin MJ; Ross R; Salenius SA; D'Amico AV
    Cancer; 2011 Jan; 117(2):406-13. PubMed ID: 21108457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.
    Nanda A; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    JAMA; 2009 Aug; 302(8):866-73. PubMed ID: 19706860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke.
    Hayes JH; Chen MH; Moran BJ; Braccioforte MH; Dosoretz DE; Salenius S; Katin MJ; Ross R; Choueiri TK; D'Amico AV
    BJU Int; 2010 Oct; 106(7):979-85. PubMed ID: 20230380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer.
    Hoffman KE; Chen MH; Moran BJ; Braccioforte MH; Dosoretz D; Salenius S; Katin MJ; Ross R; D'Amico AV
    Cancer; 2010 Jun; 116(11):2590-5. PubMed ID: 20310055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy.
    Dosoretz AM; Chen MH; Salenius SA; Ross RH; Dosoretz DE; Katin MJ; Mantz C; Nakfoor BM; D'Amico AV
    Cancer; 2010 Feb; 116(4):837-42. PubMed ID: 20052734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based study of cardiovascular mortality among patients with prostate cancer treated with radical external beam radiation therapy with and without adjuvant androgen deprivation therapy at the British Columbia Cancer Agency.
    Kim J; Vaid M; Tyldesley S; Woods R; Pickles T
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):742-50. PubMed ID: 20630664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction.
    Nguyen PL; Chen MH; Beckman JA; Beard CJ; Martin NE; Choueiri TK; Hu JC; Hoffman KE; Dosoretz DE; Moran BJ; Salenius SA; Braccioforte MH; Kantoff PW; D'Amico AV; Ennis RD
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1411-6. PubMed ID: 21708431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapy.
    Nanda A; Chen MH; Moran BJ; Braccioforte MH; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e209-15. PubMed ID: 23332383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.
    D'Amico AV; Moran BJ; Braccioforte MH; Dosoretz D; Salenius S; Katin M; Ross R; Chen MH
    J Clin Oncol; 2009 Aug; 27(24):3923-8. PubMed ID: 19597029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
    Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH
    N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
    Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL;
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery revascularization and the risk of death in men with prostate cancer.
    D'Amico AV; Chen MH; Dosoretz D; Katin M; Salenius S; Ross R; Goldhaber SZ
    J Urol; 2011 Sep; 186(3):898-902. PubMed ID: 21788044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.
    Kintzel PE; Chase SL; Schultz LM; O'Rourke TJ
    Pharmacotherapy; 2008 Dec; 28(12):1511-22. PubMed ID: 19025432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?
    Stone NN; Marshall DT; Stone JJ; Cesaretti JA; Stock RG
    J Urol; 2010 Feb; 183(2):634-9. PubMed ID: 20018308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators.
    Detre KM; Lombardero MS; Brooks MM; Hardison RM; Holubkov R; Sopko G; Frye RL; Chaitman BR
    N Engl J Med; 2000 Apr; 342(14):989-97. PubMed ID: 10749960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.
    Beyer DC; McKeough T; Thomas T
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1299-305. PubMed ID: 15817331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.